Cargando…

Association of anti-oxidative capacity of HDL with subclinical atherosclerosis in subjects with and without non-alcoholic fatty liver disease

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) patients are at a substantial risk for developing cardiovascular disease (CVD). High-density lipoprotein (HDL) is well known to have protective effects against the development of atherosclerotic CVD. One of the major antiatherogenic effects of HD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karami, Sara, Poustchi, Hossein, Sarmadi, Negar, Radmard, Amir Reza, Ali Yari, Fatemeh, Pakdel, Abbas, Shabani, Parisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8549143/ https://www.ncbi.nlm.nih.gov/pubmed/34702329 http://dx.doi.org/10.1186/s13098-021-00741-5

Ejemplares similares

Anti-inflammatory function of apolipoprotein B-depleted plasma is impaired in non-alcoholic fatty liver disease
por: Sarmadi, Negar, et al.
Publicado: (2022)

Circulating levels of FAM19A5 are inversely associated with subclinical atherosclerosis in non-alcoholic fatty liver disease
por: Yari, Fatemeh Ali, et al.
Publicado: (2021)

Impaired HDL cholesterol efflux capacity in patients with non-alcoholic fatty liver disease is associated with subclinical atherosclerosis
por: Fadaei, Reza, et al.
Publicado: (2018)

HDL cholesterol efflux capacity in rheumatoid arthritis patients: contributing factors and relationship with subclinical atherosclerosis
por: Tejera-Segura, Beatriz, et al.
Publicado: (2017)

Roles of the Metabolic Syndrome, HDL Cholesterol, and Coronary Atherosclerosis in Subclinical Inflammation
por: Rein, Philipp, et al.
Publicado: (2010)

HDL Size is More Accurate than HDL Cholesterol to Predict Carotid Subclinical Atherosclerosis in Individuals Classified as Low Cardiovascular Risk
por: Parra, Eliane Soler, et al.
Publicado: (2014)

Circulating Level of CTRP1 in Patients with Nonalcoholic Fatty Liver Disease (NAFLD): Is It through Insulin Resistance?
por: Shabani, Parisa, et al.
Publicado: (2015)

The Association between HDL-C and Subclinical Atherosclerosis Depends on CETP Plasma Concentration: Insights from the IMPROVE Study
por: Colombo, Gualtiero I., et al.
Publicado: (2021)

HDL, Atherosclerosis, and Emerging Therapies
por: Hafiane, Anouar, et al.
Publicado: (2013)

Lack of Correlation of Plasma HDL With Fecal Cholesterol and Plasma Cholesterol Efflux Capacity Suggests Importance of HDL Functionality in Attenuation of Atherosclerosis
por: Srivastava, Neelam, et al.
Publicado: (2018)

Circulating Tryptase as a Marker for Subclinical Atherosclerosis in Obese Subjects
por: Moreno, María, et al.
Publicado: (2014)

The incidence of subclinical atherosclerosis in subjects with low and moderate cardiovascular risk
por: Li, Yan, et al.
Publicado: (2023)

Dietary total antioxidant capacity is inversely associated with the odds of non-alcoholic fatty liver disease in people with type-2 diabetes
por: Salavatizadeh, Marieh, et al.
Publicado: (2022)

The association of circulating levels of complement-C1q TNF-related protein 5 (CTRP5) with nonalcoholic fatty liver disease and type 2 diabetes: a case–control study
por: Emamgholipour, Solaleh, et al.
Publicado: (2015)

Curcumin and inflammation in non-alcoholic fatty liver disease: a randomized, placebo controlled clinical trial
por: Saadati, Saeede, et al.
Publicado: (2019)

Significance of Microalbuminuria in Relation to Subclinical Coronary Atherosclerosis in Asymptomatic Nonhypertensive, Nondiabetic Subjects
por: Park, Hyo Eun, et al.
Publicado: (2013)

Detection of Subclinical Atherosclerosis in Asymptomatic Subjects Using Ultrasound Radiofrequency-Tracking Technology
por: Niu, Lili, et al.
Publicado: (2014)

Influence of Metabolic Syndrome on Small, Dense LDL, and Subclinical Atherosclerosis in Older Subjects
por: Yoshino, Hiroshi, et al.
Publicado: (2023)

Cardiac Insulin Resistance in Subjects With Metabolic Syndrome Traits and Early Subclinical Atherosclerosis
por: Devesa, Ana, et al.
Publicado: (2023)

Nonalcoholic Fatty Liver Disease Is Associated with the Presence and Morphology of Subclinical Coronary Atherosclerosis
por: Kang, Min Kyoung, et al.
Publicado: (2015)

Nonalcoholic Fatty Liver Disease in Hispanic Youth With Dysglycemia: Risk for Subclinical Atherosclerosis?
por: Bacha, Fida, et al.
Publicado: (2017)

Association of non-alcoholic fatty liver disease with cardiovascular disease and subclinical atherosclerosis
por: Sao, Rahul, et al.
Publicado: (2017)

Association and Prediction of Subclinical Atherosclerosis by Nonalcoholic Fatty Liver Disease in Asymptomatic Patients
por: Bae, Ye Seul, et al.
Publicado: (2020)

Subclinical atherosclerosis in patients with psoriasis
por: Balta, Ilknur, et al.
Publicado: (2015)

Diabetes and Subclinical Coronary Atherosclerosis
por: Lee, Chang Hoon, et al.
Publicado: (2018)

Predictors of subclinical atherosclerosis in HIV
por: Fernández Soto, Julia, et al.
Publicado: (2023)

HDL-Mediated Cholesterol Efflux and Plasma Loading Capacities Are Altered in Subjects with Metabolically- but Not Genetically Driven Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Di Costanzo, Alessia, et al.
Publicado: (2020)

Impact of cardiovascular and immunologic variables on subclinical carotid atherosclerosis in subjects with anti-phospholipid antibodies
por: Di Minno, Matteo Nicola Dario, et al.
Publicado: (2018)

Association of α-klotho with subclinical carotid atherosclerosis in subjects with type 1 diabetes mellitus
por: Castelblanco, Esmeralda, et al.
Publicado: (2022)

HDL Improves Cholesterol and Glucose Homeostasis and Reduces Atherosclerosis in Diabetes-Associated Atherosclerosis
por: Di Bartolo, Belinda A., et al.
Publicado: (2021)

ApoCIII enrichment in HDL impairs HDL-mediated cholesterol efflux capacity
por: Luo, Mengdie, et al.
Publicado: (2017)

Is subclinical atherosclerosis associated with visceral fat and fatty liver in adolescents with type 1 diabetes?
por: Atwa, Hoda, et al.
Publicado: (2018)

Factors influencing subclinical atherosclerosis in patients with biopsy-proven nonalcoholic fatty liver disease
por: Arai, Taeang, et al.
Publicado: (2019)

The inverse association of serum HBV DNA level with HDL and adiponectin in chronic hepatitis B infection
por: Mohamadkhani, Ashraf, et al.
Publicado: (2010)

HDL cholesterol efflux capacity is inversely associated with subclinical cardiovascular risk markers in young adults: The cardiovascular risk in Young Finns study
por: Hunjadi, Monika, et al.
Publicado: (2020)

Current and Emerging Reconstituted HDL-apoA-I and HDL-apoE Approaches to Treat Atherosclerosis
por: Valanti, Eftaxia-Konstantina, et al.
Publicado: (2018)

Association of Endothelial and Oxidative Stress with Metabolic Syndrome and Subclinical Atherosclerosis: Multi-Ethnic Study of Atherosclerosis
por: Vaidya, Dhananjay, et al.
Publicado: (2011)

Testosterone replacement in hypogonadal men alters the HDL proteome but not HDL cholesterol efflux capacity
por: Rubinow, Katya B., et al.
Publicado: (2012)

Noninvasive indicators of atherosclerosis in subclinical hypothyroidism
por: Kilic, Ismail Dogu, et al.
Publicado: (2013)

Association of Fat Density With Subclinical Atherosclerosis
por: Alvey, Nicholas J., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_tunq6cievqekmmungpr506fv22